BRIEF

on Cheplapharm Arzneimittel GmbH (isin : DE000CHP2222)

CHEPLAPHARM Reorganizes Management Team

CHEPLAPHARM Group, headquartered in Greifswald, is restructuring its management team for future growth. As of 1 July 2024, Artem Gevorkyan has joined as Senior Vice President (SVP) Corporate Business Development. He previously worked at Sandoz and will be responsible for business development, mergers & acquisitions, and portfolio management.

Karl ‘Charly’ Lang will now lead the Supply Chain & Logistics division as Vice President (VP) across the entire CHEPLAPHARM Group. He assumes this role following Klaus Köhl, who is leaving the company at his own request.

Edeltraud Lafer, CEO of CHEPLAPHARM, expressed confidence in these appointments, stating that they are vital for the company’s future direction. She thanked Klaus Köhl for his contributions and wished him well.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Cheplapharm Arzneimittel GmbH news